...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Exploring new inhibitors of Plasmodium falciparum purine nucleoside phosphorylase.
【24h】

Exploring new inhibitors of Plasmodium falciparum purine nucleoside phosphorylase.

机译:探索恶性疟原虫嘌呤核苷磷酸化酶的新抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Plasmodium falciparum purine nucleoside phosphorylase (PfPNP) has a central role in purine salvage and inhibitors of the enzyme have been shown to have antiplasmodial activity. The enzyme preferentially uses inosine as substrate (K(m)=5 muM, k(cat)/K(m)=7.4x10(4) M(-1) s(-1)), but can also use uridine, albeit less efficiently (K(m)=85 muM, k(cat)/K(m)=306 M(-1) s(-1)). In an effort to identify new PfPNP inhibitors, two series of compounds were prepared. Series 1 was based on known human uridine phosphorylase inhibitors whilst series 2 was uracil equivalents of purine-based PNP transition state inhibitors. These two series of compounds were assayed for inhibition of both PfPNP activity and growth of P. falciparum. The transition state analogues were found to be moderate inhibitors of PfPNP (most potent compound, K(i)=6 muM).
机译:恶性疟原虫嘌呤核苷磷酸化酶(PfPNP)在嘌呤挽救中起着核心作用,该酶的抑制剂已显示具有抗血浆活性。该酶优先使用肌苷作为底物(K(m)= 5μM,k(cat)/ K(m)= 7.4x10(4)M(-1)s(-1)),但也可以使用尿苷效率较低(K(m)= 85μM,k(cat)/ K(m)= 306 M(-1)s(-1))。为了鉴定新的PfPNP抑制剂,制备了两个系列的化合物。系列1是基于已知的人尿苷磷酸化酶抑制剂,而系列2是基于嘌呤的PNP过渡态抑制剂的尿嘧啶等效物。测定了这两个系列化合物对PfPNP活性和恶性疟原虫生长的抑制。发现过渡态类似物是PfPNP的中度抑制剂(最有效的化合物,K(i)=6μM)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号